• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

United States

MA strategy deal block push come together form
Manufacturing

Germany's LTS boosts US drug delivery CDMO footprint through M&A

As U.S. production investments continue to roll in this year, Germany's LTS Lohmann has struck a deal to boost its CDMO firepower in the States.
Fraiser Kansteiner Oct 13, 2025 10:49am
graphic image of China flags overlapping with US flags

Senate backs China competition amendment in defense bill

Oct 10, 2025 10:56am
launch button
Sponsored

With EuroAPI site, Particle Dynamics merges into new CDMO Codis

Oct 15, 2025 10:42am
Virginia

AZ breaks ground on $4.5B API production facility in Virginia

Oct 9, 2025 1:45pm
Biopharma biotech biotech industry biopharma industry science microscope DNA double helix

Regulatory, policy uncertainties harm biopharma planning: Cytiva

Oct 8, 2025 3:11pm
Surescripts settlement commentary

Gilead inks Biktarvy settlements with 3 generic drug makers

Oct 7, 2025 7:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings